Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bioaffinity technologies, inc. symbols : BIAF save search
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -7.22%
H: 0.0%
C: -3.33%
lung initiative cancer for
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 2.97%
H: 1.92%
C: 0.48%
year financial results
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board
Published: 2024-02-06 (Crawled : 13:30) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -0.38%
H: 0.64%
C: -0.64%
lung network medical
bioAffinity Technologies In The News - January 30, 2024
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 2.5%
H: 0.51%
C: -2.44%
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer - January 23, 2024
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 5.3%
H: 0.0%
C: -2.52%
award patent cancer treatment
bioAffinity Technologies In the News
Published: 2024-01-08 (Crawled : 14:30) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 7.22%
H: 0.0%
C: -4.88%
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Published: 2023-11-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 0.6%
H: 0.0%
C: -2.39%
lung cancer
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -2.33%
H: 7.14%
C: 2.93%
business update financial results
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 5.49%
H: 0.0%
C: -8.05%
sales
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 8.33%
H: 0.0%
C: -5.59%
conference growth
Funds' Portfolios Must Reflect Their Name, SEC Says | PLANADVISER – PLANADVISER
Published: 2023-09-20 (Crawled : 23:00) - spacfeed.com
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
AMERGIN ASSET MANAGEMENT ANNOUNCES ACQUISITION OF … – PR Newswire
Published: 2023-09-20 (Crawled : 23:00) - spacfeed.com
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
management acquisition
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF … – PR Newswire
Published: 2023-09-20 (Crawled : 22:00) - spacfeed.com
BGC | $7.72 0.13% 0.13% 3.4M
|
n/a
|
| O: -2.07%
H: 3.37%
C: 1.73%
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
ICCT | $1.17 -1.28% 58K
|
Professional, Scientific, and T...
|
| O: -6.11%
H: 21.95%
C: 10.03%
network
PRIME AE Enhances Midwest Presence with Jacobi, Toombs … – PR Newswire
Published: 2023-09-20 (Crawled : 22:00) - spacfeed.com
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
ICCT | $1.17 -1.28% 58K
|
Professional, Scientific, and T...
|
| O: -6.11%
H: 21.95%
C: 10.03%
prime
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
Published: 2023-09-19 (Crawled : 14:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -0.05%
H: 1.18%
C: -3.58%
services
bioAffinity Technologies Presents Research Findings at CYTO 2023
Published: 2023-05-22 (Crawled : 14:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 0.0%
H: 3.83%
C: 3.83%
research
bioAffinity Technologies Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -5.37%
H: 5.67%
C: 3.96%
financial results
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
Published: 2023-05-01 (Crawled : 13:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: -0.51%
H: 7.22%
C: 5.67%
financial
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 2.44%
H: 0.0%
C: -2.38%
lung symposium cancer
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
Published: 2023-03-28 (Crawled : 13:00) - biospace.com/
BIAF | $2.99 7.55% 7.02% 240K
|
|
| O: 1.76%
H: 2.03%
C: -6.03%
cypath lung cancer publication
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.